Page last updated: 2024-08-24

ibandronic acid and Lupus Erythematosus, Systemic

ibandronic acid has been researched along with Lupus Erythematosus, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goossens, N; Rubbia-Brandt, L; Spahr, L1
Griffith, JF; Hung, VY; Kwok, AW; Lee, KK; Lee, VW; Leung, PC; Li, EK; Li, M; Qin, L; Tam, LS; Wong, KC; Zhu, TY1

Trials

1 trial(s) available for ibandronic acid and Lupus Erythematosus, Systemic

ArticleYear
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
    Arthritis research & therapy, 2010, Volume: 12, Issue:5

    Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Prednisolone; Tomography Scanners, X-Ray Computed

2010

Other Studies

1 other study(ies) available for ibandronic acid and Lupus Erythematosus, Systemic

ArticleYear
Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report.
    Journal of hepatology, 2013, Volume: 59, Issue:5

    Topics: Adrenal Cortex Hormones; Chemical and Drug Induced Liver Injury; Contraindications; Diphosphonates; Female; Humans; Hydroxychloroquine; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Steroids; Treatment Outcome; Withholding Treatment

2013
chemdatabank.com